As you know, Next Science is a company whose purpose is to improve people’s health by eliminating or preventing infections. Through our unique technologies we have helped tens of thousands of people resume normal life and as we increase our focus on infection prevention, we look forward to the opportunity of quietly protecting millions of people from the complications of post operative infection.
Moving to slide 3. In this report, I’ll focus on our platform technology and products, the execution milestones we have achieved in the last half and the progress we are making in attaining VAC approvals to commercialise XPerience – our market leading No Rinse Antimicrobial Solution that has been launched in the United States. I will explain the VAC process later in the presentation.
For more information, download the attached PDF.
Download this document
